|
|
XEN
|
Abstract:
Purpose: To evaluate the 3-year efficiency and safety of XEN® 45 gel stent implantation in a heterogenous group of open angle glaucoma patients. Methods: In this prospective, non-randomized observational study we identified patients who had undergone either stand-alone XEN® implantation (XEN solo) or XEN® implantation in combination with phacoemulsification (XEN combi). All patients who had undergone an implantation during the period 01.04.17-31.10.19 at the Department of Ophthalmology, Drammen Hospital, Norway, were asked to participate. Success was defined as IOP between 5 - 18 mmHg and 20% pressure reduction without medications. Qualified success required the same pressure interval and reduction but allowed medications. The procedure was deemed as failure if pressure requirements were not met, vision was reduced to light perception or worse, or if there was a converion to secondary glaucoma surgery. Results: Out of 115 patients and 133 eyes identified, 87 patients and 99 eyes consented to participate. All patients were Caucasians with a mean age of 73.6 years. The study had a mean (range) follow-up of 38.9 (28 - 54) months. The mean medicated baseline (SD) was reduced from 22.6 (7.9) mmHg on 3.2 (1.1) medications to 14.2 (5.6) mmHg on 1.4 (1.6) medications. Success and qualified success were achieved in 22.2% and 21.2%, respectively. Needling was performed in 34 eyes. Conclusion: XEN® 45 gel stent implantation is a safe procedure, offering a significantly lower IOP and number of medications in a subset of patients with open angle glaucoma.
| [1] | Tham, Y.-C., Li, X., Wong, T.Y., Quigley, H.A., Aung, T. and Cheng, C.-Y. (2014) Global Prevalence of Glaucoma and Projections of Glaucoma Burden through 2040: A Systematic Review and Meta-Analysis. Ophthalmology, 121, 2081-2090. https://doi.org/10.1016/j.ophtha.2014.05.013 |
| [2] | Coleman, A.L. and Miglior, S. (2008) Risk Factors for Glaucoma Onset and Progression. Survey of Ophthalmology, 53, S3-S10. https://doi.org/10.1016/j.survophthal.2008.08.006 |
| [3] | Fechtner, R.D., Godfrey, D.G., Budenz, D., Stewart, J.A., Stewart, W.C. and Jasek, M.C. (2010) Prevalence of Ocular Surface Complaints in Patients with Glaucoma Using Topical Intraocular Pressure-Lowering Medications. Cornea, 29, 618-621. https://doi.org/10.1097/ICO.0b013e3181c325b2 |
| [4] | Leung, E.W., Medeiros, F.A. and Weinreb, R.N. (2008) Prevalence of Ocular Surface Disease in Glaucoma Patients. Journal of Glaucoma, 17, 350-355. https://doi.org/10.1097/IJG.0b013e31815c5f4f |
| [5] | Jha, B., Bhartiya, S., Sharma, R., Arora, T. and Dada, T. (2012) Selective Laser Trabeculoplasty: An Overview. Journal of Current Glaucoma Practice, 6, 79-90. https://doi.org/10.5005/jp-journals-10008-1111 |
| [6] | Vinod, K., Gedde, S.J., Feuer, W.J., Panarelli, J.F., Chang, T.C., Chen, P.P., et al. (2017) Practice Preferences for Glaucoma Surgery: A Survey of the American Glaucoma Society. Journal of Glaucoma, 26, 687-693. https://doi.org/10.1097/IJG.0000000000000720 |
| [7] | Gedde, S.J., Singh, K., Schiffman, J.C. and Feuer, W.J. (2012) The Tube versus Trabeculectomy Study: Interpretation of Results and Application to Clinical Practice. Current Opinion in Ophthalmology, 23, 118-126. https://doi.org/10.1097/ICU.0b013e32834ff2d1 |
| [8] | Kotecha, A., Feuer, W.J., Barton, K. and Gedde, S.J. (2017) Quality of Life in the Tube versus Trabeculectomy Study. American Journal of Ophthalmology, 176, 228-235. https://doi.org/10.1016/j.ajo.2017.01.019 |
| [9] | Kirwan, J.F., Lockwood, A.J., Shah, P., Macleod, A., Broadway, D.C., King, A.J., et al. (2013) Trabeculectomy in the 21st Century: A Multicenter Analysis. Ophthalmology, 120, 2532-2539. https://doi.org/10.1016/j.ophtha.2013.07.049 |
| [10] | Sheybani, A., Reitsamer, H. and Ahmed, I.I.K. (2015) Fluid Dynamics of a Novel Micro-Fistula Implant for the Surgical Treatment of Glaucoma. Investigative Ophthalmology & Visual Science, 56, 4789-4795. https://doi.org/10.1167/iovs.15-16625 |
| [11] | Fea, A.M., Durr, G.M., Marolo, P., Malinverni, L., Economou, M.A. and Ahmed, I. (2020) XEN® Gel Stent: A Comprehensive Review on Its Use as a Treatment Option for Refractory Glaucoma. Clinical Ophthalmology, 14, 1805-1832. https://doi.org/10.2147/OPTH.S178348 |
| [12] | Galal, A., Bilgic, A., Eltanamly, R. and Osman, A. (2017) XEN Glaucoma Implant with Mitomycin C 1-Year Follow-up: Result and Complications. Journal of Ophthalmology, 2017, Article ID: 5457246. https://doi.org/10.1155/2017/5457246 |
| [13] | De Gregorio, A., Pedrotti, E., Russo, L. and Morselli, S. (2018) Minimally Invasive Combined Glaucoma and Cataract Surgery: Clinical Results of the Smallest Ab Interno Gel Stent. International Ophthalmology, 38, 1129-1134. https://doi.org/10.1007/s10792-017-0571-x |
| [14] | Mansouri, K., Guidotti, J., Rao, H.L., Ouabas, A., D’Alessandro, E., Roy, S., et al. (2018) Prospective Evaluation of Standalone XEN Gel Implant and Combined Phacoemulsification-XEN Gel Implant Surgery: 1-Year Results. Journal of Glaucoma, 27, 140-147. https://doi.org/10.1097/IJG.0000000000000858 |
| [15] | Tan, S.Z., Walkden, A. and Au, L. (2018) One-Year Result of XEN45 Implant for Glaucoma: Efficacy, Safety, and Postoperative Management. Eye, 32, 324-332. https://doi.org/10.1038/eye.2017.162 |
| [16] | Ibanez-Munoz, A., Soto-Biforcos, V.S., Chacon-Gonzalez, M., Rua-Galisteo, O., Arrieta-Los Santos, A., Lizuain-Abadia, M.E., et al. (2019) One-Year Follow-Up of the XEN® Implant with Mitomycin-C in Pseudoexfoliative Glaucoma Patients. European Journal of Ophthalmology, 29, 309-314. https://doi.org/10.1177/1120672118795063 |
| [17] | Reitsamer, H., Vera, V., Ruben, S., Au, L., Vila-Arteaga, J., Teus, M., et al. (2022) Three-Year Effectiveness and Safety of the XEN Gel Stent as a Solo Procedure or in Combination with Phacoemulsification in Open-Angle Glaucoma: A Multicentre Study. Acta Ophthalmologica, 100, e233-e245. https://doi.org/10.1111/aos.14886 |
| [18] | Gillmann, K., Bravetti, G.E., Rao, H.L., Mermoud, A. and Mansouri, K. (2021) Combined and Stand-Alone XEN 45 Gel Stent Implantation: 3-Year Outcomes and Success Predictors. Acta Ophthalmologica, 99, e531-e539. https://doi.org/10.1111/aos.14605 |
| [19] | Gabbay, I.E., Goldberg, M., Allen, F., Lin, Z., Morley, C., Pearsall, T., et al. (2021) Efficacy and Safety Data for the Ab Interno XEN45 Gel Stent Implant at 3 Years: A Retrospective Analysis. European Journal of Ophthalmology, 32, 1016-1022. https://doi.org/10.1177/11206721211014381 |
| [20] | Grover, D.S., Flynn, W.J., Bashford, K.P., Lewis, R.A., Duh, Y.J., Nangia, R.S., et al. (2017) Performance and Safety of a New Ab Interno Gelatin Stent in Refractory Glaucoma at 12 Months. American Journal of Ophthalmology, 183, 25-36. https://doi.org/10.1016/j.ajo.2017.07.023 |
| [21] | Pérez-Torregrosa, V.T., Olate-Pérez, A., Cerdà-Ibáñez, M., Gargallo-Benedicto, A., Osorio-Alayo, V., Barreiro-Rego, A., et al. (2016) Combined Phacoemulsification and XEN45 Surgery from a Temporal Approach and 2 Incisions. Archivos de la Sociedad Española de Oftalmología (English Edition), 91, 415-421. https://doi.org/10.1016/j.oftale.2016.05.004 |
| [22] | Widder, R.A., Dietlein, T.S., Dinslage, S., Kuhnrich, P., Rennings, C. and Rossler, G. (2018) The XEN45 Gel Stent as a Minimally Invasive Procedure in Glaucoma Surgery: Success Rates, Risk Profile, and Rates of Re-Surgery after 261 Surgeries. Graefe’s Archive for Clinical and Experimental Ophthalmology, 256, 765-771. https://doi.org/10.1007/s00417-018-3899-7 |
| [23] | Karimi, A., Lindfield, D., Turnbull, A., Dimitriou, C., Bhatia, B., Radwan, M., et al. (2019) A Multi-Centre Interventional Case Series of 259 Ab-Interno Xen Gel Implants for Glaucoma, with and without Combined Cataract Surgery. Eye, 33, 469-477. https://doi.org/10.1038/s41433-018-0243-8 |
| [24] | Chen, X.-Z., Liang, Z.-Q., Yang, K.-Y., Lv, K., Ma, Y., Li, M.-Y., et al. (2022) The Outcomes of XEN Gel Stent Implantation: A Systematic Review and Meta-Analysis. Frontiers in Medicine, 9, Article 804847. https://doi.org/10.3389/fmed.2022.804847 |
| [25] | Heidinger, A., Schwab, C., Lindner, E., Riedl, R. and Mossbock, G. (2019) A Retrospective Study of 199 Xen45 Stent Implantations from 2014 to 2016. Journal of Glaucoma, 28, 75-79. https://doi.org/10.1097/IJG.0000000000001122 |
